Roy Haskell

1.1k total citations
19 papers, 655 citations indexed

About

Roy Haskell is a scholar working on Pharmaceutical Science, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, Roy Haskell has authored 19 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 7 papers in Materials Chemistry and 4 papers in Organic Chemistry. Recurrent topics in Roy Haskell's work include Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (7 papers) and Advancements in Transdermal Drug Delivery (3 papers). Roy Haskell is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Crystallization and Solubility Studies (7 papers) and Advancements in Transdermal Drug Delivery (3 papers). Roy Haskell collaborates with scholars based in United States, China and Germany. Roy Haskell's co-authors include Michael J. Hageman, Feng Qian, Munir Hussain, Kevin Stefanski, Ching Su, Yuejie Chen, Chengyu Liu, Zhen Chen, Shujing Wang and Shan Wang and has published in prestigious journals such as Journal of Neuroscience, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Roy Haskell

19 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Haskell United States 12 483 266 129 101 74 19 655
Duk Soon Choi United States 9 466 1.0× 276 1.0× 126 1.0× 137 1.4× 78 1.1× 12 592
James D. Ormes United States 13 457 0.9× 269 1.0× 115 0.9× 89 0.9× 58 0.8× 20 575
Hiroshi Ueda Japan 14 388 0.8× 235 0.9× 98 0.8× 101 1.0× 53 0.7× 37 627
M. Crew United States 2 397 0.8× 181 0.7× 101 0.8× 95 0.9× 67 0.9× 2 511
Tu Van Duong United States 13 370 0.8× 231 0.9× 70 0.5× 89 0.9× 63 0.9× 15 482
Krishna Hari Bhandari South Korea 11 387 0.8× 159 0.6× 128 1.0× 76 0.8× 116 1.6× 16 594
Madhuri Newa South Korea 11 387 0.8× 159 0.6× 126 1.0× 76 0.8× 116 1.6× 15 584
M. Serpil Kislalioglu United States 11 456 0.9× 231 0.9× 74 0.6× 121 1.2× 128 1.7× 14 633
Catarina Marques Fernandes Portugal 7 359 0.7× 147 0.6× 98 0.8× 126 1.2× 98 1.3× 10 517
Niels Erik Olesen Denmark 12 349 0.7× 247 0.9× 102 0.8× 160 1.6× 66 0.9× 17 567

Countries citing papers authored by Roy Haskell

Since Specialization
Citations

This map shows the geographic impact of Roy Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Haskell more than expected).

Fields of papers citing papers by Roy Haskell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Haskell. The network helps show where Roy Haskell may publish in the future.

Co-authorship network of co-authors of Roy Haskell

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Haskell. A scholar is included among the top collaborators of Roy Haskell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Haskell. Roy Haskell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Huang, Liping, et al.. (2019). Tunable Two-Compartment On-Demand Sustained Drug Release Based on Lipid Gels. Journal of Pharmaceutical Sciences. 109(2). 1059–1067. 8 indexed citations
2.
Guarino, Victor R., Richard E. Olson, Ivar M. McDonald, et al.. (2019). An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS–708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog. Bioorganic & Medicinal Chemistry Letters. 30(3). 126856–126856. 8 indexed citations
3.
Morgen, Michael M., Xueqing Chen, Warren K. Miller, et al.. (2017). Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery. European Journal of Pharmaceutics and Biopharmaceutics. 117. 212–223. 47 indexed citations
4.
Morrison, J. S., et al.. (2017). A polychromatic turbidity microplate assay to distinguish discovery stage drug molecules with beneficial precipitation properties. International Journal of Pharmaceutics. 531(1). 24–34. 3 indexed citations
5.
Chen, Huijun, Chengyu Liu, Zhen Chen, et al.. (2017). Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance. Journal of Pharmaceutical Sciences. 107(1). 317–326. 60 indexed citations
6.
Haskell, Roy, et al.. (2017). Biorelevant Media Slows the Solution-Mediated Phase Transformation of Amorphous Spironolactone. Journal of Pharmaceutical Sciences. 107(1). 426–435. 3 indexed citations
7.
Chen, Yuejie, Shujing Wang, Shan Wang, et al.. (2016). Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction. Pharmaceutical Research. 33(10). 2445–2458. 106 indexed citations
8.
Chen, Yuejie, Shujing Wang, Shan Wang, et al.. (2016). Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion. Molecular Pharmaceutics. 13(8). 2787–2795. 65 indexed citations
9.
Thakker, Deepak R., Sethu Sankaranarayanan, Marcy R. Weatherspoon, et al.. (2015). Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice. Journal of Neuroscience. 35(17). 6931–6936. 26 indexed citations
10.
11.
Morrison, J. S., et al.. (2014). A Combination Turbidity and Supernatant Microplate Assay to Rank‐Order the Supersaturation Limits of Early Drug Candidates. Journal of Pharmaceutical Sciences. 103(10). 3022–3032. 20 indexed citations
12.
Subramanian, Murali, Matthew G. Soars, John J. Herbst, et al.. (2014). A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model. Drug Metabolism Letters. 8(2). 109–118. 16 indexed citations
13.
Chen, Yuejie, Chengyu Liu, Zhen Chen, et al.. (2014). Drug–Polymer–Water Interaction and Its Implication for the Dissolution Performance of Amorphous Solid Dispersions. Molecular Pharmaceutics. 12(2). 576–589. 150 indexed citations
14.
Prisinzano, Thomas E., Roy Haskell, Stephen R. Byrn, & Allen C. Templeton. (2014). Discovering and Developing Molecules with Optimal Drug-Like Properties. DIAL (Catholic University of Leuven). 38 indexed citations
15.
Haskell, Roy, et al.. (2012). Surfactant choice and the physical stability of nanosuspensions as a function of pH. International Journal of Pharmaceutics. 439(1-2). 1–7. 10 indexed citations
16.
Morgen, Michael M., Guang Wei Lu, Randall G. Stehle, et al.. (2011). Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions. International Journal of Pharmaceutics. 416(1). 314–22. 30 indexed citations
17.
Haskell, Roy. (2006). Physical Characterization of Nanoparticles. 127–162. 5 indexed citations
18.
Gao, Ping, et al.. (2004). Application of a Mixture Experimental Design in the Optimization of a Self‐Emulsifying Formulation with a High Drug Load. Pharmaceutical Development and Technology. 9(3). 301–309. 28 indexed citations
19.
Haskell, Roy. (1998). Characterization of Submicron Systems via Optical Methods. Journal of Pharmaceutical Sciences. 87(2). 125–129. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duk Soon Choi Breakdown of academic impact, for papers by James D. Ormes Breakdown of academic impact, for papers by Hiroshi Ueda Breakdown of academic impact, for papers by M. Crew Breakdown of academic impact, for papers by Tu Van Duong Breakdown of academic impact, for papers by Krishna Hari Bhandari Breakdown of academic impact, for papers by Madhuri Newa Breakdown of academic impact, for papers by M. Serpil Kislalioglu Breakdown of academic impact, for papers by Catarina Marques Fernandes Breakdown of academic impact, for papers by Niels Erik Olesen
Rankless by CCL
2026